Queen's Award Received in 2021 ISO 9001 Certified Delivered over 1,000,000 bio-reagents to life science researchers Trusted by Life Science Communities
Cart summary

You have no items in your shopping cart.

YU238259

SKU: orb1302938

Description

YU238259 is a selective small molecule inhibitor of homology-directed repair (HDR) that spares non-homologous end joining (NHEJ), as demonstrated in cellular GFP reporter assays. This tool compound is useful for studying DNA repair pathway choice, synthetic lethality, and radiosensitization in both in vitro and in vivo cancer research models.

Research Area

Molecular Biology, Signal Transduction

Images & Validation

Key Properties

CAS Number1943733-16-1
MW459.95
Purity99.12% (May vary between batches)
FormulaC22H22ClN3O4S
SMILESCOc1ccc(cc1)S(=O)(=O)NCc1ccc(cc1)C(=O)NCCc1ccc(Cl)cn1
TargetDNA-PK
SolubilityH2O:< 1 mg/mL (insoluble or slightly soluble);DMSO:84 mg/mL (182.63 mM);10% DMSO+90% Corn Oil:3.3 mg/mL (7.17 mM);Ethanol:< 1 mg/mL (insoluble or slightly soluble)

Bioactivity

In Vivo
Growth of BRCA2-deficient human tumor xenografts in nude mice is significantly delayed by YU238259 treatment even without concomitant DNA-damaging therapy.
In Vitro
YU238259 sensitizes tumor cells to radiation therapy and DSB-inducing chemotherapy. Treatment with YU238259 is not only synergistic with ionizing radiation (IR), etoposide, and PARP inhibition, but this synergism is heightened by BRCA2-deficiency. Synthetic lethality of YU238259 in HDR-deficient cells results from accumulation of unresolved DSBs following additional inhibition of residual HDR pathway activity. Inhibition of HDR activity by YU238259 has little to no effect on the NHEJ pathway.
Cell Research
U2OS cells were pretreated with 25 μM YU238259 or DMSO vehicle for 1 h and cells were then irradiated with 10 Gy IR. Cells were fixed at 8 h post-IR, stained with antibodies and Hoechst dye, and imaged. Foci were quantified using the InCell Analyzer algorithm developed by YCMD. Cells were scored as foci-positive if they contained ≥15 foci (BRCA1, pDNA-PK) or ≥20 foci (53BP1).
Animal Research
Animal Models: 069(nu)/070(nu/+) athymic nude mice. Formulation: 3:1 DMSO:PBS. Dosages: 3 mg/kg . Administration: i.p

Storage & Handling

Storage-20°C
Expiration Date12 months from date of receipt.
DisclaimerFor research use only

Alternative Names

Inhibitor, inhibit, HDR, DNAPK, DNA-PK, DNA-dependent protein kinase, YU 238259, YU238259, YU-238259

Similar Products

  • YU 238259 [orb1225796]

    >98% (HPLC)

    1943733-16-1

    459.95

    C22H22ClN3O4S

    25 mg, 50 mg, 100 mg, 2 mg, 5 mg, 10 mg, 500 mg, 1 g
Quality Guarantee

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].

Key Properties

No computed properties available.

Protocol Information

Available Sizes

Select a size below

1 mg
$ 80.00
2 mg
$ 100.00
1 ml x 10 mM (in DMSO)
$ 130.00
5 mg
$ 130.00
10 mg
$ 200.00
25 mg
$ 370.00
50 mg
$ 620.00
100 mg
$ 870.00
500 mg
$ 1,730.00
DispatchUsually dispatched within 3-5 working days
Bulk Enquiry